Adaption of Medication Adherence Management Guidelines on Highly Active Antiretroviral Therapy_Chinese Journal of Evidence-Based Medicine

Authors：

 FULiang ¹ ,  HUYan ¹ , LUHong-zhou ² , SHENYin-zhong ² , BAOMei-juan ² , ZHANGLin ²

1. School of Nursing, Fudan University/Fudan Center for Evidence-based Nursing:A Collaborative Center with Joanna Briggs, Fudan University, Shanghai 200030, China;
2. Department of Infectious Disease, Shanghai Public Health Clinical Center Affiliated to Fudan University, Shanghai 200083, China;

Corresponding author：

HUYan, Email: huyan@fudan.edu.cn

Keywords：

Acquired immunodeficiency syndrome; Highly active antiretroviral therapy; Medication adherence; Clinical practice guideline; Guidelines adaption

DOI：

10.7507/1672-2531.20150025

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To adapt existing clinical practice guidelines to the management of medication adherence to highly active antiretroviral therapy (HAART) in China, so as to provide evidence to support the development of practice guidelines that meet China's actual conditions. Methods According to ADAPTE methodology and status of HAART in China, we searched, appraised, selected and adapted current clinical practice guidelines on the management of medication adherence to HAART. Results A total of 10 guidelines were included, and the final clinical practice guidelines for the management of medication adherence to HAART involved 3 aspects, including influential factors, assessment methods, and interventions. High quality evidence resources had been formed, and the quality of final clinical practice guidelines was higher. Conclusion It is feasible to develop clinical practice guidelines according to the ADAPTE method, and reliable evidence support has been provided for the development of clinical practice guidelines based on guideline adaption.

Citation： FULiang, HUYan, LUHong-zhou, SHENYin-zhong, BAOMei-juan, ZHANGLin. Adaption of Medication Adherence Management Guidelines on Highly Active Antiretroviral Therapy. Chinese Journal of Evidence-Based Medicine, 2015, 15(2): 137-143. doi: 10.7507/1672-2531.20150025 Copy

1.	Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons:analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr, 2006, 41(2):194-200.
2.	Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study:an observational study. Lancet, 2003, 362(9377):22-29.
3.	Yeni PG, Hammer SM, Hirsch MS, et al. Treatment for adult HIV infection:2004 recommendations of the International AIDS Society-USA Panel. JAMA, 2004, 292(2):251-265.
4.	Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 2001, 15(9):1181-1183.
5.	Oyugi JH, Byakika-Tusiime J, Ragland K, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS, 2007, 21(8):965-971.
6.	Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med, 2000, 342(13):921-929.
7.	傅亮, 胡雁, 鲍美娟, 等. 国内外艾滋病护理研究的发展及其启示. 护理学杂志, 2013, 28(7):90-93.
8.	The ADAPTE Collaboration. Manual for guideline adaptation. Perthshire:The ADAPTE Collaboration, 2007. Available at:http://www.agreetrust.org/.
9.	The ADAPTE Collaboration. Guideline adaption:a resource toolkit. Perthshire:The ADAPTE Collaboration, 2009. Available at:http://www.agreetrust.org/.
10.	傅亮. 艾滋病临床护理实践指南的构建研究. 上海:复旦大学, 2014.
11.	傅亮, 胡雁, 卢洪洲, 等. HIV感染者和AIDS患者抗病毒治疗护理需求及其影响因素. 护理学杂志, 2014, 29(12):24-27.
12.	中华医学会感染病学分会艾滋病学组. 艾滋病诊疗指南(2011版). 中华传染病杂志, 2011, 29(10):629-640.
13.	Graham ID, Logan J. Innovations in knowledge transfer and continuity of care. Can J Nurs Res, 2004, 36(2):89-103.
14.	胡雁. 循证护理学. 北京:人民卫生出版社, 2012:151-153.
15.	The Appraisal of Guidelines for Research & Evaluation Next Steps Research Consortium. The appraisal of guidelines for research & evaluation Ⅱ. The Appraisal of Guidelines for Research & Evaluation Enterprise, 2009. Available at:http://www.agreetrust.org/.
16.	Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Department of Health and Human Services, 2013. Available at:http://aidsinfo.nih.gov/guidelines/html/1/adultand-adolescent-arv-guidelines/0/.
17.	Gallant JE. Johns Hopkins HIV Guide. Jones & Bartlett Learning:Burlington, 2012:378-413.
18.	Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV:evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med, 2012, 156(11):817-833, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294.
19.	Asboe D, Aitken C, Boffito M, et al. British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med, 2012, 13(1):1-44.
20.	HIV/AIDS Bureau. Guide for HIV/AIDS Clinical Care. Health Resources and Services Administration, 2011. Available at:http://hab.hrsa.gov/deliverhivaidscare/clinicalguide11/.
21.	Nunes V, Neilson J, O'Flynn N, et al. Medicines adherence:Involving patients in decisions about prescribed medicines and supporting adherence. National Collaborating Centre for Primary Care and Royal College of General Practitioners, 2009. Available at:http://www.nice.org.uk/Guidance/CG76.
22.	European AIDS Clinical Society. European AIDS Clinical Society Guidelines. European AIDS Clinical Society, 2012. Available at:http://www.eacsociety.org/Portals/0/140601_EACS%20EN7.02.pdf.
23.	Williams I, Churchill D, Anderson J, et al. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012. HIV Med, 2012, 13 Suppl 2:1-85.
24.	Centers for Disease Control and Prevention. Compendium of Evidence-Based HIV Behavioral Interventions:Medication Adherence Chapter. Centers for Disease Control and Prevention, 2010. Available at:http://www.cdc.gov/hiv/prevention/research/compendium/ma/index.html.
25.	Field MJ, Lohr KN. Clinical practice guidelines:directions for a new program. National Academy Press:Washington, DC, 1990:33.
26.	Alonso-Coello P, Irfan A, Sola I, et al. The quality of clinical practice guidelines over the last two decades:a systematic review of guideline appraisal studies. Qual Saf Health Care, 2010, 19(6):e58.
27.	Adaptation Working Group. History of the ADAPTE Collaboration. Adaptation Working Group, 2012. Available at:http://www.g-i-n.net/working-groups/adaptation/history.
28.	胡晶, 陈茹, 谢雁鸣, 等. 科学和规范的改编临床实践指南. 中国循证儿科杂志, 2012(03):226-230.

1. Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons:analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr, 2006, 41(2):194-200.
2. Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study:an observational study. Lancet, 2003, 362(9377):22-29.
3. Yeni PG, Hammer SM, Hirsch MS, et al. Treatment for adult HIV infection:2004 recommendations of the International AIDS Society-USA Panel. JAMA, 2004, 292(2):251-265.
4. Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 2001, 15(9):1181-1183.
5. Oyugi JH, Byakika-Tusiime J, Ragland K, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS, 2007, 21(8):965-971.
6. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med, 2000, 342(13):921-929.
7. 傅亮, 胡雁, 鲍美娟, 等. 国内外艾滋病护理研究的发展及其启示. 护理学杂志, 2013, 28(7):90-93.
8. The ADAPTE Collaboration. Manual for guideline adaptation. Perthshire:The ADAPTE Collaboration, 2007. Available at:http://www.agreetrust.org/.
9. The ADAPTE Collaboration. Guideline adaption:a resource toolkit. Perthshire:The ADAPTE Collaboration, 2009. Available at:http://www.agreetrust.org/.
10. 傅亮. 艾滋病临床护理实践指南的构建研究. 上海:复旦大学, 2014.
11. 傅亮, 胡雁, 卢洪洲, 等. HIV感染者和AIDS患者抗病毒治疗护理需求及其影响因素. 护理学杂志, 2014, 29(12):24-27.
12. 中华医学会感染病学分会艾滋病学组. 艾滋病诊疗指南(2011版). 中华传染病杂志, 2011, 29(10):629-640.
13. Graham ID, Logan J. Innovations in knowledge transfer and continuity of care. Can J Nurs Res, 2004, 36(2):89-103.
14. 胡雁. 循证护理学. 北京:人民卫生出版社, 2012:151-153.
15. The Appraisal of Guidelines for Research & Evaluation Next Steps Research Consortium. The appraisal of guidelines for research & evaluation Ⅱ. The Appraisal of Guidelines for Research & Evaluation Enterprise, 2009. Available at:http://www.agreetrust.org/.
16. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Department of Health and Human Services, 2013. Available at:http://aidsinfo.nih.gov/guidelines/html/1/adultand-adolescent-arv-guidelines/0/.
17. Gallant JE. Johns Hopkins HIV Guide. Jones & Bartlett Learning:Burlington, 2012:378-413.
18. Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV:evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med, 2012, 156(11):817-833, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294.
19. Asboe D, Aitken C, Boffito M, et al. British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med, 2012, 13(1):1-44.
20. HIV/AIDS Bureau. Guide for HIV/AIDS Clinical Care. Health Resources and Services Administration, 2011. Available at:http://hab.hrsa.gov/deliverhivaidscare/clinicalguide11/.
21. Nunes V, Neilson J, O'Flynn N, et al. Medicines adherence:Involving patients in decisions about prescribed medicines and supporting adherence. National Collaborating Centre for Primary Care and Royal College of General Practitioners, 2009. Available at:http://www.nice.org.uk/Guidance/CG76.
22. European AIDS Clinical Society. European AIDS Clinical Society Guidelines. European AIDS Clinical Society, 2012. Available at:http://www.eacsociety.org/Portals/0/140601_EACS%20EN7.02.pdf.
23. Williams I, Churchill D, Anderson J, et al. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012. HIV Med, 2012, 13 Suppl 2:1-85.
24. Centers for Disease Control and Prevention. Compendium of Evidence-Based HIV Behavioral Interventions:Medication Adherence Chapter. Centers for Disease Control and Prevention, 2010. Available at:http://www.cdc.gov/hiv/prevention/research/compendium/ma/index.html.
25. Field MJ, Lohr KN. Clinical practice guidelines:directions for a new program. National Academy Press:Washington, DC, 1990:33.
26. Alonso-Coello P, Irfan A, Sola I, et al. The quality of clinical practice guidelines over the last two decades:a systematic review of guideline appraisal studies. Qual Saf Health Care, 2010, 19(6):e58.
27. Adaptation Working Group. History of the ADAPTE Collaboration. Adaptation Working Group, 2012. Available at:http://www.g-i-n.net/working-groups/adaptation/history.
28. 胡晶, 陈茹, 谢雁鸣, 等. 科学和规范的改编临床实践指南. 中国循证儿科杂志, 2012(03):226-230.

Previous Article
Doctors' Workload in China: A Status-quo Study
Next Article
Critical Appraisal of Clinical Practice Guidelines for Pancreatic Cancer Based on the Global Disease Burden

Chinese Journal of Evidence-Based Medicine

Adaption of Medication Adherence Management Guidelines on Highly Active Antiretroviral Therapy

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content